within Pharmacolibrary.Drugs.C_CardiovascularSystem.C08D_SelectiveCalciumChannelBlockersWithDirectCardiac.C08DA01_Verapamil;

model Verapamil_1
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 9.333333333333334e-06,
    adminDuration = 600,
    adminMass = 10 / 1000000,
    adminCount = 1,
    Vd = 0.0029,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.0044800000000000005,
    k12 = 6.666666666666667e-06,
    k21 = 6.666666666666667e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Verapamil_1</td></tr><tr><td>ATC code:</td><td>C08DA01_1</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>10</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>2.9</td><td>L</td></tr>
    <tr><td>clearance:</td><td>33.6</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Verapamil is a calcium channel blocker used therapeutically to treat hypertension, angina pectoris, and certain arrhythmias such as supraventricular tachycardia. It is approved for use and remains in clinical use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters after intravenous bolus administration in healthy adult males.</p><h4>References</h4><ol><li><p>Kaisbain, N, et al., &amp; Kaisbain, V (2023). Verapamil-Induced Hypotension in End-Stage Renal Disease: The Role of Calcium Gluconate. <i>Cureus</i> 15(1) e33341–None. DOI:<a href=\"https://doi.org/10.7759/cureus.33341\">10.7759/cureus.33341</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36741660/\">https://pubmed.ncbi.nlm.nih.gov/36741660</a></p></li><li><p>Abernethy, DR (1989). The pharmacokinetic profile of amlodipine. <i>American heart journal</i> 118(5 Pt 2) 1100–1103. DOI:<a href=\"https://doi.org/10.1016/0002-8703(89)90834-x\">10.1016/0002-8703(89)90834-x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2530866/\">https://pubmed.ncbi.nlm.nih.gov/2530866</a></p></li><li><p>Klotz, U (1998). Effect of age on pharmacokinetics and pharmacodynamics in man. <i>International journal of clinical pharmacology and therapeutics</i> 36(11) 581–585. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9849746/\">https://pubmed.ncbi.nlm.nih.gov/9849746</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.C.C08DA01_1 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Verapamil_1;
